View this email in your browserhttp://us3.campaign-archive1.com/?u=eae5bfcdc68eabe292cb4c3b1&id=4405526175&e=3a74303b16

[https://gallery.mailchimp.com/eae5bfcdc68eabe292cb4c3b1/images/brain_canada_...]

To all,

Brain Canada is pleased to launch a new funding program in partnership with CQDM that will provide $10 million to support the development of innovative tools, technologies and platforms to accelerate the discovery of new, safe and effective drugs for disorders of the brain and nervous system.

This new program intends to bridge the gap in neuroscience by supporting innovative translational research with tangible results that impact the drug discovery process, with the ultimate goal to prevent, treat or cure neurological or mental health disorders for the benefit of patients and their families. The program aims to foster multidisciplinary research collaborations linking Quebec and other Canadian researchers, as well as the academic and Small and Medium Enterprises (SMEs).

The deadline to submit a Letter of Intent (LOI) is August 20th, 2014.

For more information, please visit Brain Canada's website: http://braincanada.ca/en/Focus_on_Brainhttp://braincanada.us3.list-manage1.com/track/click?u=eae5bfcdc68eabe292cb4c3b1&id=9d088237fa&e=3a74303b16

We thank you in advance for disseminating in your networks.

The Brain Canada Team